This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (85)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Experience at a University Hospital, 1981 Through 1988

Tomas J. Sanabria, MD; Joseph S. Alpert, MD; Robert Goldberg, PhD; Linda A. Pape, MD; Sarah H. Cheeseman, MD

Arch Intern Med. 1990;150(6):1305-1309.

Abstract
• To determine the characteristics of infective endocarditis in our hospital, we reviewed all patients with that diagnosis at the University of Massachusetts Medical Center, Worcester, between 1981 and 1988. Of 113 patients with infective endocarditis, 56 (50%) had staphylococcal endocarditis. Despite aggressive medical and surgical therapy, in-hospital mortality was 25%. Forty-five (80%) of the 56 cases of staphylococcal endocarditis involved Staphylococcus aureus with a mortality of 28% vs 9% in the non–S aureus group. Mortality was higher in patients with congestive heart failure (35%), atrioventricular block (45%), atrial fibrillation (42%), and prosthetic valve endocarditis (50%). Seventy-six percent of the patients with congestive heart failure required surgery. Patients with congestive heart failure and S aureus infection had a mortality of 45%. Thirty-six patients (64%) were alive at late follow-up (mean, 28.6 months). Mortality was highest (23%) during the first 3 months following diagnosis of staphylococcal endocarditis. Staphylococcal endocarditis represents an increasingly large proportion of patients with infectious endocarditis. Mortality rates remain high despite aggressive management of the patient's condition.

(Arch Intern Med. 1990;150:1305-1309)

Author Affiliations
From the Divisions of Cardiovascular Medicine and Infectious Disease, University of Massachusetts Medical Center, Worcester.

Footnotes
Accepted for publication December 27,1989.

Reprint requests to Division of Cardiovascular Medicine, University of Massachusetts Medical Center, 55 Lake Ave N, Worcester, MA 01655 (Dr Alpert).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito et al.
ANN INTERN MED 2009;150:586-594.
ABSTRACT | FULL TEXT  

Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model
Sandberg et al.
Antimicrob. Agents Chemother. 2009;53:1874-1883.
ABSTRACT | FULL TEXT  

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
Murdoch et al.
Arch Intern Med 2009;169:463-473.
ABSTRACT | FULL TEXT  

Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Remadi et al.
Ann. Thorac. Surg. 2007;83:1295-1302.
ABSTRACT | FULL TEXT  

Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens
Nadji et al.
Heart 2005;91:932-937.
ABSTRACT | FULL TEXT  

Early Predictors of In-Hospital Death in Infective Endocarditis
Chu et al.
Circulation 2004;109:1745-1749.
ABSTRACT | FULL TEXT  

Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler et al.
Arch Intern Med 2003;163:2066-2072.
ABSTRACT | FULL TEXT  

Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study
Koegelenberg et al.
QJM 2003;96:217-225.
ABSTRACT | FULL TEXT  

Changing Patient Characteristics and the Effect on Mortality in Endocarditis
Cabell et al.
Arch Intern Med 2002;162:90-94.
ABSTRACT | FULL TEXT  

Evidence of Less Severe Aortic Valve Destruction after Treatment of Experimental Staphylococcal Endocarditis with Vancomycin and Dexamethasone
Siaperas et al.
Antimicrob. Agents Chemother. 2001;45:3531-3537.
ABSTRACT | FULL TEXT  

Back pain and dyspnoea in a middle aged diabetic male
Postgrad. Med. J. 2000;76:243b-243.
FULL TEXT  

Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia
Rosen et al.
ANN INTERN MED 1999;130:810-820.
ABSTRACT | FULL TEXT  

Clinical Features of Staphylococcus aureus Endocarditis: A 10-Year Experience in Denmark
Roder et al.
Arch Intern Med 1999;159:462-469.
ABSTRACT | FULL TEXT  

Comparative Efficacy of Trovafloxacin in Experimental Endocarditis Caused by Ciprofloxacin-Sensitive, Methicillin-Resistant Staphylococcus aureus
Kim et al.
Antimicrob. Agents Chemother. 1998;42:3325-3327.
ABSTRACT | FULL TEXT  

Staphylococcus aureus Infections
Lowy
NEJM 1998;339:520-532.
FULL TEXT  

Diagnosis of Infective Endocarditis: Sensitivity of the Duke vs von Reyn Criteria
Heiro et al.
Arch Intern Med 1998;158:18-24.
ABSTRACT | FULL TEXT  

Endocarditis in an Urban Hospital in the 1990s
Siddiq et al.
Arch Intern Med 1996;156:2454-2458.
ABSTRACT  

Staphylococcus aureus Endocarditis at a Community Teaching Hospital, 1980 to 1991: An Analysis of 106 Cases
Watanakunakorn
Arch Intern Med 1994;154:2330-2335.
ABSTRACT  

The Complications of Infective Endocarditis: A Reappraisal in the 1980s
Mansur et al.
Arch Intern Med 1992;152:2428-2432.
ABSTRACT  

Epidemiology of Bacterial Endocarditis in the Netherlands: I. Patient Characteristics
van der Meer et al.
Arch Intern Med 1992;152:1863-21868.
ABSTRACT